NCT05591456 is a Phase 3 clinical trial of adjuvant radiotherapy in Breast Cancer Radiotherapy, sponsored by Zagazig University.

Who is sponsoring NCT05591456?

NCT05591456 is sponsored by Zagazig University.

What drugs are being tested in NCT05591456?

Interventions in NCT05591456: adjuvant radiotherapy.

What condition does NCT05591456 study?

NCT05591456 studies Breast Cancer Radiotherapy.

Is NCT05591456 still recruiting?

NCT05591456 is currently completed. Last updated 25 October 2022.

Last reviewed 2022-10-25 · How we verify

NCT05591456

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients

Completed Phase 3 Last updated 25 October 2022

What this trial tests

Phase 3 trial testing adjuvant radiotherapy in Breast Cancer Radiotherapy in 100 participants. Completed in 30 June 2019.

Timeline

1 January 2018

Primary endpoint
30 June 2019

30 June 2019

Quick facts

Lead sponsor	Zagazig University
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	1 January 2018
Primary completion	30 June 2019
Estimated completion	30 June 2019
Sites	1 location across Egypt

Drugs / interventions tested

adjuvant radiotherapy

Conditions studied

Breast Cancer Radiotherapy — all drugs for Breast Cancer Radiotherapy →

Sponsor

Zagazig University

Who can join

Adults 18 to 80, female only, with Breast Cancer Radiotherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Accelerated hypofractionated 1 week post-mastectomy chest wall irradiation in breast cancer patients will presumably produce comparable toxicity and disease control in comparison to 3 weeks schedule. The aim is to evaluate toxicity and disease control after implementation of accelerated hypofractionated 1 week chest wall irradiation in breast cancer patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of adjuvant radiotherapy

Trials testing the same drug.

NCT06524167 — RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer · recruiting
NCT06313073 — Neoadjuvant Radiotherapy for Breast Cancer · NA · unknown

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05591456 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 25 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05591456.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing